Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01854151 · ClinicalTrials.gov registry record · NA
Promoting Safe Use of Pediatric Liquid Medications
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1,005
- Enrollment target
NCT01854151 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1,005 participants.
The verdict
NCT01854151, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,005 participants
- Enrollment target
Study Summary
Variable and poor-quality drug labeling has been cited as a leading cause of medication errors and adverse drug events, especially in the context of low health literacy. This is a particularly important issue in pediatrics as more than half of US children are exposed to one or more outpatient medications in a given week, and studies suggest that over half of caregivers make errors when dosing liquid medications for children. Our study objective is to identify evidence-based strategies for labeling and dosing prescription and over-the-counter pediatric liquid medications in order to promote safe, appropriate use, as well as to inform state and federal policy standards. We hypothesize that a health literacy-informed labeling and dosing strategy will result in improved parent ability to administer medications prescribed to their young children.
Interventions
- OTHER New Labeling/Dosing Strategy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,005 participants |
| Start Date | 2013-04-22 |
| Est. Completion | 2019-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01854151
The ClinicalTrials.gov registry entry for NCT01854151 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,005 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which New Labeling/Dosing Strategy is the first listed.
NCT01854151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01854151 about?
NCT01854151 is a clinical study titled "Promoting Safe Use of Pediatric Liquid Medications". Variable and poor-quality drug labeling has been cited as a leading cause of medication errors and adverse drug events, especially in the context of low health literacy. This is a particularly important issue in pediatrics as more than half of US children are exposed to one or more outpatient medica...
What is the current status of trial NCT01854151?
This trial is currently completed. It is a NA study. The enrollment target is 1,005 participants. The study started on 2013-04-22. Estimated completion is 2019-03-25.
What interventions are being tested in trial NCT01854151?
The interventions under investigation include: New Labeling/Dosing Strategy (OTHER).
Who is sponsoring clinical trial NCT01854151?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.